The high price of anticancer drugs: origins, implications, barriers, solutions


Globally, annual spending on anticancer drugs is around US$100 billion, and is predicted to rise to $150 billion by 2020. In the USA, a novel anticancer drug routinely costs more than $100,000 per year of treatment. When adjusted for per capita spending power, however, drugs are most unaffordable in economically developing nations, such as India and China… (More)
DOI: 10.1038/nrclinonc.2017.31


4 Figures and Tables

Blog articles referencing this paper